NDC 22431-124

Epsom Salts Relief

Magnesium Sulfate Heptahydrate

Epsom Salts Relief is a Oral Granule in the Human Otc Drug category. It is labeled and distributed by Blue Cross Laboratories, Inc.. The primary component is Magnesium Sulfate Heptahydrate.

Product ID22431-124_d9a45311-8050-5f59-e053-2995a90a10c5
NDC22431-124
Product TypeHuman Otc Drug
Proprietary NameEpsom Salts Relief
Generic NameMagnesium Sulfate Heptahydrate
Dosage FormGranule
Route of AdministrationORAL
Marketing Start Date2010-07-09
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameBlue Cross Laboratories, Inc.
Substance NameMAGNESIUM SULFATE HEPTAHYDRATE
Active Ingredient Strength100 g/100g
Pharm ClassesCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 22431-124-01

1810 g in 1 BAG (22431-124-01)
Marketing Start Date2015-04-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 22431-124-02 [22431012402]

Epsom Salts Relief GRANULE
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-04-24

NDC 22431-124-01 [22431012401]

Epsom Salts Relief GRANULE
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-04-24

NDC 22431-124-03 [22431012403]

Epsom Salts Relief GRANULE
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-04-24

NDC 22431-124-04 [22431012404]

Epsom Salts Relief GRANULE
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-04-24

Drug Details

Active Ingredients

IngredientStrength
MAGNESIUM SULFATE HEPTAHYDRATE100 g/100g

OpenFDA Data

SPL SET ID:d4937f2c-095d-40ca-94e7-6d88df95768e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1053346

    • NDC Crossover Matching brand name "Epsom Salts Relief" or generic name "Magnesium Sulfate Heptahydrate"

    NDCBrand NameGeneric Name
    59779-541CVS foaming muscle reliefMagnesium Sulfate heptahydrate
    22431-124Epsom SaltsMagnesium Sulfate Heptahydrate
    0220-3267Magnesia sulphuricaMAGNESIUM SULFATE HEPTAHYDRATE
    0338-1708Magnesium SulfateMagnesium Sulfate Heptahydrate
    0338-1715Magnesium SulfateMagnesium Sulfate Heptahydrate
    0338-1719Magnesium SulfateMagnesium Sulfate Heptahydrate
    0404-9903Magnesium SulfateMagnesium Sulfate Heptahydrate
    25021-612Magnesium SulfateMagnesium Sulfate Heptahydrate
    47335-992MAGNESIUM SULFATEmagnesium sulfate heptahydrate
    50090-3323magnesium sulfateMAGNESIUM SULFATE HEPTAHYDRATE
    51754-1000Magnesium SulfateMAGNESIUM SULFATE HEPTAHYDRATE
    52584-754Magnesium SulfateMagnesium Sulfate Heptahydrate
    55154-9358Magnesium SulfateMAGNESIUM SULFATE HEPTAHYDRATE
    0264-4400Magnesium Sulfate in Dextrosemagnesium sulfate heptahydrate
    0264-4204Magnesium Sulfate in Watermagnesium sulfate heptahydrate
    0264-4205Magnesium Sulfate in Watermagnesium sulfate heptahydrate
    0264-4206Magnesium Sulfate in Watermagnesium sulfate heptahydrate
    22431-248Relief Epsom SaltMagnesium Sulfate Heptahydrate
    61594-003Theraworx Relief Muscle Cramp and Spasm ReliefMAGNESIUM SULFATE HEPTAHYDRATE
    61594-004Theraworx Relief Muscle Cramp and Spasm ReliefMAGNESIUM SULFATE HEPTAHYDRATE
    0363-9820WG 110 Walgreens FoamerMAGNESIUM SULFATE HEPTAHYDRATE

    Trademark Results [Epsom Salts]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EPSOM SALTS
    EPSOM SALTS
    98255460 not registered Live/Pending
    Limin Chen
    2023-11-05
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.